About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Enabling Discovery, Development, and Translation of ... Released: July 22, 2015
    On February 24, 2015, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous Disorders convened key stakeholders at a workshop in Washington, DC, to explore how best to enable the discovery, development, and translation of treatments for cognitive dysfunction in depression, including a focus on the regulatory path forward.
  • Psychosocial Interventions for Mental and Substance Use ... Released: July 14, 2015
    The Institute of Medicine (IOM) convened an expert committee to identify key steps to ensure that evidence-based, high-quality care is provided to individuals receiving mental health and substance use services. The resulting report, Psychosocial Interventions for Mental and Substance Use Disorders, details the reasons for the gap between what is known to be effective and what is currently practiced, and it offers recommendations for how best to address this gap by proposing a framework that can be used to establish standards for psychosocial interventions.
  • Financial Incentives to Encourage Development of Therapies ... Released: July 06, 2015
    The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20–21, 2015, to explore policy changes that might increase private sector investment in research and development (R&D) innovation that fills unmet medical needs for CNS disorders.
  • Preventing Intimate Partner Violence in Uganda, Kenya, and ... Released: June 18, 2015
    On August 11–12, 2014, the Institute of Medicine’s (IOM’s) Forum on Global Violence Prevention, in a collaborative partnership with the Uganda National Academy of Sciences (UNAS), convened a workshop focused on informing and creating synergies within a diverse community of researchers, health workers, and decision makers committed to promoting IPV-prevention efforts that are innovative, evidence-based, and crosscutting. This collaborative workshop also fulfills the forum’s mandate, which in part requires it to engage in multisectoral, multidirectional dialogue that explores crosscutting approaches to violence prevention.
  • Developing a 21st Century Neuroscience Workforce ... Released: April 21, 2015
    Given the changing landscape resulting from technological advances and the growing importance of interdisciplinary and collaborative science, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders convened a workshop on October 28 and 29, 2014, in Washington, DC, to explore future workforce needs and how these needs should inform training programs.
  • Psychological Testing in the Service of Disability ... Released: April 10, 2015
    The U.S. Social Security Administration (SSA) asked the Institute of Medicine (IOM) to convene a committee of relevant experts to review selected psychological tests, including SVTs and PVTs, and to evaluate the value of and provide guidance on the use of such testing in the adjudication of claims submitted to the SSA Disability Programs.
  • Harvesting the Scientific Investment in Prevention Science to ... Released: April 01, 2015
    With more than 200 prevention-centered, evidence-based health interventions in their toolbox, pediatric health practitioners stand to reap a bounty of benefits for their clients and communities. But how should all these data be harvested and evaluated, particularly in light of the changes introduced by the Affordable Care Act (ACA) and the Mental Health Parity and Addiction Equity Act of 2008, as well as reduced funding, implementation barriers, and the demands of balancing public health against individual patient treatment choices?
  • Strategies for Scaling Tested and Effective Family-Focused ... Released: April 01, 2015
    On April 1–2, 2014, the Board on Children, Youth, and Families of the Institute of Medicine and the National Research Council held a 2-day workshop titled “Strategies for Scaling Tested and Effective Family-Focused Preventive Interventions to Promote Children’s Cognitive, Affective, and Behavioral Health.” The purpose of the workshop was to discuss the successes and challenges of scaling family-focused interventions.
  • Innovations in Design and Utilization of Measurement ... Released: March 31, 2015
    The workshop featured presentations on the use of data linkage and integration to inform research and practice related to children’s cognitive, affective, and behavioral health; the use of quality measures to facilitate system change in health care, classroom, and juvenile justice settings; and tools developed to measure implementation of evidence-based prevention programs at scale to support sustainable program delivery, among other topics.
  • Public Health Implications of Raising the Minimum Age of ... Released: March 12, 2015
    In 2013, as requested by the U.S. Food and Drug Administration (FDA), the IOM convened a committee to conduct a study on the public health implications of raising the minimum age to purchase tobacco products. In the report, Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products, the committee of experts reviews existing literature on tobacco use initiation, developmental biology and psy¬chology, and tobacco policy and predicts the likely public health outcomes of raising the MLA for tobacco products to 19 years, 21 years, and 25 years. The committee also uses mathematical modeling to quantify these predictions.